Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Singlas

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
International Journal of Clinical Pharmacology and Therapeutics|November 1, 1995
Cimetidine does not alter sparfloxacin pharmacokineticsJ M Gries, J Honorato, A M Taburet, et al.
Clinical Pharmacokinetics|July 1, 1990
Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysisE Singlas, A Leroy, E Sultan, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patientsA M Taburet, C Katlama, C Blanshard, et al.
The Journal of Pediatrics|June 1, 1993
Randomized study of two doses of didanosine in children infected with human immunodeficiency virusS Blanche, T Calvez, C Rouzioux, et al.
Revue Neurologique|February 1, 1978
[Neurological disorders and perhexiline maleate therapy. Clinical study of 10 cases. Neuropathological, pharmacocinetic and biochemical studies (author's transl)]J Nick, P Dudognon, R Escourolle, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysisE Singlas, A M Taburet, F Borsa Lebas, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
International Journal of Clinical Pharmacology and Therapeutics|November 1, 1995
Cimetidine does not alter sparfloxacin pharmacokineticsJ M Gries, J Honorato, A M Taburet, et al.
Clinical Pharmacokinetics|July 1, 1990
Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysisE Singlas, A Leroy, E Sultan, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patientsA M Taburet, C Katlama, C Blanshard, et al.
The Journal of Pediatrics|June 1, 1993
Randomized study of two doses of didanosine in children infected with human immunodeficiency virusS Blanche, T Calvez, C Rouzioux, et al.
Revue Neurologique|February 1, 1978
[Neurological disorders and perhexiline maleate therapy. Clinical study of 10 cases. Neuropathological, pharmacocinetic and biochemical studies (author's transl)]J Nick, P Dudognon, R Escourolle, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysisE Singlas, A M Taburet, F Borsa Lebas, et al.
Pageof 6